Prognostic significance of MAPK, Topo IIα and E-cadherin immunoexpression in ovarian serous carcinomas von Sundov, D, Petric Mise, B, Mrklic, I, Bacic, B, Vrdoljak, E, Tomic, S

Volltext

Optimisation of breast cancer patients' follow‐up – potential way to improve cancer care in transitional countries von Bošković, L., Gašparić, M., Petrić Miše, B., Petković, M., Gugić, D., Ban, M., Jazvić, M., Dabelić, N., Belac Lovasić, I., Vrdoljak, E.

Volltext

Retrospective analysis of efficacy of trastuzumab in adjuvant treatment of HER 2 positive early breast cancer - single institution experience von Ban, M, Viculin, J, Tomic, S, Capkun, V, Strikic, A, Mise, B Petric, Utrobicic, I, Vrdoljak, E

Volltext

A retrospective study of cancer testis antigens MAGE-A1 and MAGE-A4 expression in high grade endometrial cancer von Juretic, A, Srdelic Mihalj, S, Kuzmic-Prusac, I, Spagnoli, G, Vrdoljak, E, Petric-Mise, B, Capkun, V

Volltext

Efficacy and safety of TC dose-dense chemotherapy as first-line treatment of epithelial ovarian cancer: a single-institution retrospective cohort study von Vrdoljak, J, Boban, T, Petrić Miše, B, Boraska Jelavić, T, Bajić, Ž, Tomić, S, Vrdoljak, E

Volltext

691 - A retrospective study of cancer testis antigens MAGE-A1 and MAGE-A4 expression in high grade endometrial cancer von Juretic, A., Srdelic Mihalj, S., Kuzmic-Prusac, I., Spagnoli, G., Vrdoljak, E., Petric-Mise, B., Capkun, V.

Volltext